Skip to main content
CHCT logo

CHCT · Community Healthcare Trust Inc

Track CHCT — free
$14.50 +0.04 (+0.28%) At close · Nov 18
Market Cap
$416.72M
Shares
28.74M
Volume · Nov 18 226.83K Avg daily vol (3M) 368.39K

Price & Indicators

Drag to pan · scroll to zoom
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$14.50 Open$14.38 Day$14.36–14.57 52W close$12.64–19.02 Avg vol 30d347K Short int870K · 3.0% of shares · 2.5d Short vol47% Last earningsNov 4, 2026 DataJan 2020–Nov 2026 Filing10-Q · Nov 3

Up next

Feb 16, 2027 Est · unconfirmed · in 13 wks

Latest documents

2026
Nov 4
Earnings call
Occupancy rises to 90.1% as FFO grows 10.4%

Community Healthcare Trust reported third-quarter occupancy of 90.1%, up from 89.8%, and FFO of $15 million, up 10.4% year over year. It signed agreements for four properties totaling $99 million, with expected returns of 9.1% to 9.75%.

4 source passages
Occupancy increased from 89.8% in the second quarter to 90.1% in the third quarter. FFO in the third quarter of 2026 was $15 million, a 10.4% increase year over year compared to the $13.5 million of FFO in the third quarter of 2025. we have signed definitive purchase and sale agreements for four properties to be acquired upon completion and occupancy for an aggregate expected purchase price of $99 million. The expected return on These investments should range from 9.1% to 9.75%. Open the document at this passage
Nov 3
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Net income turns positive as FFO reaches $41,577

Community Healthcare Trust Incorporated reported nine-month net income of $7,980 compared with $(9,326), and FFO of $41,577 compared with $32,551; figures are in thousands. Four properties under definitive purchase agreements carry an aggregate expected purchase price of approximately $99.0 million.

Revenue $32.44M ▲ 4.4% Net income $3.07M ▲ 87.1% Diluted EPS $0.09 ▲ 200.0%
Read from the MD&A section
4 source passages
References such as "we," "us," "our," and "the Company" mean Community Healthcare Trust Incorporated, a Maryland corporation, and its consolidated subsidiaries. Net income (loss) | 3,068 | 1,640 | 7,980 | (9,326) FFO | 14,960 | 13,547 | 41,577 | 32,551 The Company has four properties under definitive purchase agreements, to be acquired after completion and occupancy, for an aggregate expected purchase price of approximately $99.0 million. Open the document at this passage
Nov 3
Current report 8-K
Third-quarter net income reaches $3.1 million; dividend remains $0.33

Community Healthcare Trust Incorporated reported $3.1 million in third-quarter net income, or $0.09 per diluted common share, and $0.54 of FFO and $0.58 of AFFO per diluted share. The Board declared a $0.33 quarterly dividend, unchanged from the prior quarter.

Financial results, Regulation FD disclosure Read from the first part of this long document
2 source passages
The Company reported net income for the three months ended September 30, 2026 of approximately $3.1 million, or $0.09 per diluted common share. Funds from operations ("FFO") and adjusted funds from operations ("AFFO") for the three months ended September 30, 2026 totaled $0.54 and $0.58 per diluted common share, respectively. On November 3, 2026, the Company's Board of Directors declared a quarterly common stock dividend in the amount of $0.33 per share, payable on November 25, 2026, to stockholders of record as of November 13, 2026. This is the same quarterly common stock dividend amount as the prior quarter. Open the document at this passage
All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$126.14M
Trailing 12 months
Net income (TTM)
$22.41M
Trailing 12 months
Revenue growth YoY
+4.4%
Year over year
Operating margin
—
Trailing 12 months
P / FFO
9.1×
Company-stated · FY2025 · reciprocal yield 11.0%
P / AFFO
7.1×
Company-stated · FY2025 · reciprocal yield 14.0%
P / E (TTM)
19.6
Trailing earnings · reciprocal yield 5.1%
Net cash
−$557.03M
Latest balance sheet
Dividend yield
11.2%
Trailing 12 months
Shares change YoY
+0.5%
Year over year · more shares
Price change (1Y)
-5.0%
Trailing year
Short interest
3.0%
Latest settlement · 2.5 days to cover
View all 129 metrics

AI Brief

Q2 FY26 earnings call · Aug 5, 2026
Q2 FY26

TL;DR. CHCT cut its quarterly dividend 31% to $0.33 per share, which it said will retain $25 million to $30 million over two years for acquisitions, reinvestment and occupancy improvements. The company targets 92% leased occupancy, has $99 million of acquisitions under definitive agreement, and has more than $70 million of assets marketed for sale, but transaction timing and closing remain uncertain.

Bullish
  • + Retaining $25 million to $30 million of capital over two years will fund acquisitions, portfolio reinvestments and occupancy improvements.
  • + The company has a $99 million acquisition pipeline under definitive agreement with expected returns of 9.1% to 9.75%.
  • + The company targets 92% leased occupancy, with up to $6 million of NOI upside from occupancy gains and rent growth.
  • + The company expects capital recycling proceeds to fund its high-yield acquisition pipeline while keeping leverage modest.
  • + Second-quarter revenue increased year over year to $31.2 million, while AFFO per share increased to $0.56 from $0.50.
Bearish
  • − The quarterly dividend was reduced 31% to $0.33 per share, lowering the AFFO payout ratio to approximately 60%.
  • − Leased occupancy declined to 89.8% from 90.7% a year earlier.
  • − The proposed sale of the geriatric behavioral hospital operator's business remains subject to documentation, due diligence and closing conditions, and the company cannot assure the timing or ultimate closing.
  • − The $99 million acquisition pipeline is not assured of closing on the anticipated timetable.

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Neutral
SellHoldBuy
Technical Buy Momentum Weak Sentiment Bearish Fundamentals Fair Quant / Vol Moderate
Market backdrop VIX 24.6 · elevated Equity put/call 0.72
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg −11%
below
Price vs 50-day avg +4%
above
RSI (14) 57
neutral
MACD trend Positive
52-week position 29%
mid-range
Momentum
relative strength
Weak
1-month return +15%
trailing
6-month return −16%
trailing
YTD return −12%
this year
Relative strength −12%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $14 › 200d $16 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +26 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.03% of shares out · ▲ +11.4% MoM · 2.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
167 holders — mid 3-yr range
Squeeze score 57
elevated · 0–100
Fundamentals
Fair
Revenue growth +5%
Y/Y
EPS growth +135%
Y/Y
Valuation P/E 19.6
in line
Balance sheet $528.9M
net debt
Quant / Vol
risk profile
Moderate
Volatility 30%
annualized · 1-yr
Max drawdown −34%
past year
ATR 2.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Nov 4, 2026
fourth quarter
Gain $9.1M
upon completion and occupancy
Aggregate expected purchase price $99M
Expected return on These investments 9.1% – 9.75%
Previous outlook earlier release · from the 8-K filed Nov 3, 2026

Still-open targets the latest release did not restate under the same label.

Aggregate expected purchase price · after completion and occupancy $99M
Expected returns on these investments · after completion and occupancy 9.1% – 9.75%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
1 · 3 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−11% Bearish
Price vs 50-day avg
+4% Bullish
RSI (14)
57 Neutral
MACD trend
Positive Bullish
52-week position
29% Neutral
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $14 › 200d $16 — 200d above 50d
Institutional flow Distributing
-3% holders QoQ · +26 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.03% of shares out · ▲ +11.4% MoM · 2.5 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
167 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $13 Now $15 · 29% Range high $19
vs 200-day avg -11% vs 50-day avg +4%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
% Leased 89.8% 2Q 2026 —
Adjusted EBITDAre non-GAAP $23.25M 2Q 2026 —
GAAP → non-GAAP reconciliation
EBITDAre 20.47M (the result of another reconciliation in this filing)
+2.78M Non-cash stock-based compensation expense
+0K Accelerated amortization of stock-based compensation
+0K Credit loss reserve
= Adjusted EBITDAre 23.25M
Adjusted EBITDAre Annualized non-GAAP $93M 2Q 2026 —
Adjusted funds from operations (AFFO) per Common Share-Diluted non-GAAP $0.56 Three Months Ended June 30, 2026 —
AFFO non-GAAP $15.41M 2Q 2026 —
GAAP → non-GAAP reconciliation
FFO 13.22M (non-GAAP)
-591K Straight-line rent
+2.78M Stock-based compensation
+0K Accelerated amortization of stock-based compensation
+0K Severance and transition related expenses
= AFFO 15.41M
AFFO Per Common Share non-GAAP $0.56 2Q 2026 —
Annualized NOI non-GAAP $101.44M 2Q 2026 —
Common shares outstanding 28,654,743 2Q 2026 —
Debt to Total Capitalization 43.9% 2Q 2026 —
EBITDAre non-GAAP $20.47M 2Q 2026 —
GAAP → non-GAAP reconciliation
GAAP Net income (loss) 2.36M
+7.43M Interest expense
+10.74M Depreciation and amortization
-12K Deferred Income tax (benefit) expense
-46K (Gain) loss, net of impairment, on the sale of real estate assets
= EBITDAre 20.47M
FAD non-GAAP $12.99M 2Q 2026 —
GAAP → non-GAAP reconciliation
AFFO, Adjusted for other non-cash items 15.64M (non-GAAP)
-202K Leasing commissions
-1.11M Tenant improvements
-1.34M Recurring capex
= FAD 12.99M
FFO non-GAAP $13.22M 2Q 2026 —
GAAP → non-GAAP reconciliation
GAAP Net Income (Loss) 2.36M
+10.9M Real estate depreciation and amortization
+0K Credit loss reserve
-46K (Gain) loss, net of impairment, on the sale of real estate assets
= FFO 13.22M
FFO Per Common Share non-GAAP $0.48 2Q 2026 —
Fixed charge coverage ratio 3 2Q 2026 —
Funds from operations (FFO) per Common Share-Diluted non-GAAP $0.48 Three Months Ended June 30, 2026 —
Leased occupancy Total Portfolio 89.8% 2Q 2026 —
Leased Square Feet at end of period 4.06M 2Q 2026 —
Minimum debt service coverage ratio 3.2 2Q 2026 —
NOI non-GAAP $25.36M 2Q 2026 —
GAAP → non-GAAP reconciliation
GAAP Net income (loss) 2.36M
+4.89M General and administrative
+0K Accelerated amortization of deferred compensation
+0K Severance and transition-related compensation
+10.74M Depreciation and amortization
-46K (Gain) loss, net of impairment, on the sale of real estate assets
+0K Credit loss reserve
+7.43M Interest expense
-12K Deferred Income tax (benefit) expense
-3K Interest and other income, net
= NOI 25.36M
Portfolio Occupancy 89.8% Q2 2026 —
Real estate properties (count) 197 As of June 30, 2026 —
Renewals square feet 155K 2Q 2026 —
Tangible net worth $695.59M 2Q 2026 —
Total investments in real estate properties $1.2B As of June 30, 2026 —
Total square feet owned 4,520,097 2Q 2026 —
Total square footage of properties 4.5M As of June 30, 2026 —
Weighted average common shares outstanding - diluted 27.75M Three Months Ended June 30, 2026 filing —
Weighted average common shares outstanding - FFO Diluted non-GAAP 27.75M 2Q 2026 —
Weighted Average remaining lease term (years) 7.2 2Q 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

REIT - Healthcare Facilities — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
CHCT
Community Healthcare Trust Inc
this stock
$416.72M -11.7% +4.7% 19.6 3.0%
WELL
Welltower Inc.
$181.39B +33.2% +35.6% 107.5 2.4%
VTR
Ventas, Inc.
$46.64B +14.0% +18.5% 166.4 2.8%
OHI
Omega Healthcare Investors Inc
$14.33B +6.2% +13.2% 18.9 4.8%
AHR
American Healthcare REIT, Inc.
$13.59B +24.4% +9.1% 117.1 14.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
167
% held
74.3%
Net QoQ
-1.8M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
169
View
Short & Settlement
Short Interest Rising
Shares short
870.0K
Days to cover
2.5d
Change
+88.8K sh
View
Short Volume
Short vol %
47%
As of
Nov 18, 2026
Short Total
View
Fails to Deliver
FTD shares
3
Value
$41
As of
Oct 9, 2026
View
Off-Exchange
Off-exchange %
35.8%
Week of
Oct 12, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$121.2M
Net income (FY)
$5.1M
EPS diluted
$0.08
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 3, 2026
This year
13

Community Healthcare Trust Incorporated reported nine-month net income of $7,980 compared with $(9,326), and FFO of $41,577 compared with $32,551; figures are in thousands. Four properties under definitive purchase agreements carry an aggregate expected purchase price of approximately $99.0 million.

View
Earnings & Events
Webcasts
Last webcast
Nov 4, 2026
View
Investor Relations
Latest news
Community Healthcare Trust Announ…
Published
Oct 14, 2026
View

Performance

5D 20D 120D MTD YTD
CHCT -3.4% +14.7% -15.8% +11.0% -11.7%
SPY -3.9% -5.6% -3.5% -3.4% +7.1%
vs SPY +0.5% +20.3% -12.3% +14.4% -18.8%

Capital returns

Latest dividend
$0.33 / share · ex Nov 13, 2026
Cut 31.3%
Paid (TTM)
$1.618 / share · 4 payouts
Dividend yield (TTM, derived)
11.16%
Full dividend history

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1631569 CUSIP 20369C106 13F (30d) 166 filings 151 filers Visit website Investor relations